A61K 38/08
Peptides having 5 to 11 amino acids
Official title: Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)}
A61K38/08 (Peptides having 5 to 11 amino acids) appears on 3,220 US grants and 5,556 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,220
- Published applications
- 5,556
- Assignees
- 2,081
- Inventors
- 8,101
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 4 | 0 |
| 1979 | 1 | 0 |
| 1980 | 4 | 0 |
| 1981 | 4 | 0 |
| 1982 | 2 | 0 |
| 1983 | 1 | 0 |
| 1984 | 4 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 5 | 0 |
| 1988 | 5 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 10 | 0 |
| 1992 | 11 | 0 |
| 1993 | 10 | 0 |
| 1994 | 10 | 0 |
| 1995 | 11 | 0 |
| 1996 | 23 | 0 |
| 1997 | 26 | 0 |
| 1998 | 41 | 0 |
| 1999 | 42 | 0 |
| 2000 | 47 | 0 |
| 2001 | 48 | 11 |
| 2002 | 35 | 63 |
| 2003 | 30 | 115 |
| 2004 | 29 | 126 |
| 2005 | 41 | 116 |
| 2006 | 52 | 144 |
| 2007 | 57 | 170 |
| 2008 | 39 | 150 |
| 2009 | 60 | 170 |
| 2010 | 77 | 205 |
| 2011 | 70 | 198 |
| 2012 | 85 | 159 |
| 2013 | 115 | 238 |
| 2014 | 158 | 283 |
| 2015 | 181 | 291 |
| 2016 | 190 | 322 |
| 2017 | 190 | 311 |
| 2018 | 193 | 327 |
| 2019 | 208 | 318 |
| 2020 | 236 | 361 |
| 2021 | 224 | 319 |
| 2022 | 176 | 301 |
| 2023 | 141 | 275 |
| 2024 | 122 | 240 |
| 2025 | 126 | 202 |
| 2026 | 65 | 141 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method of treating a child with central precocious puberty using an extended release composition6 Oct 2026US 12,751,990 B2Tolmar International Limited
- Methods of treating Prader Willi Syndrome and conditions associated with low basal metabolic rate or hyperphagia using a KATP channel opener29 Sep 2026US 12,746,244 B2Sedogen LLC
- Compositions and methods of using same for treating amyotrophic lateral sclerosis (ALS)29 Sep 2026US 12,746,267 B2Immunity Pharma Ltd.
- Progesterone formulation to trigger ovulation and provide luteal phase support15 Sep 2026US 12,734,179 B2Augusta University Research Institute, Inc.
- CD38 antibody drug conjugate15 Sep 2026US 12,734,209 B2Ogory, Inc.
- Compositions and methods for treatment of septic shock8 Oct 2026US 2026/0306579 A1Peroxitech Therapeutics, Inc.
- Methods of treating disease with terlipressin8 Oct 2026US 2026/0306580 A1BIOVIE, Inc.
- Intranasal desmopressin administration8 Oct 2026US 2026/0306764 A1Acerus Pharmaceuticals USA, LLC
- Water-soluble biomolecular glass microneedle and preparation method thereof1 Oct 2026US 2026/0294794 A1Institute of Process Engineering, Chinese Academy of Sciences
- Histatin for corneal wound healing and ocular surface disease1 Oct 2026US 2026/0295005 A1Visus Therapeutics, Inc.
Most cited
By later US patents
- Microencapsulation of water soluble active polypeptides483US 4,675,189 ASyntex (U.S.A.) Inc. · 1987
- Sustained delivery of leuprolide using an implantable system394US 5,728,396 AAlza Corporation · 1998
- Drug delivery system and method of making the same385US 4,897,268 ASouthern Research Institute · 1990
- Prolonged release microcapsule and its production372US 4,652,441 ATakeda Chemical Industries, Ltd. · 1987
- Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix365US 6,309,669 B1The United States of America as represented by the Secretary of the Army · 2001